Join the conversation

Together we can sharpen our thinking.

FILTER BY TYPE OF CONTENT

Announcement

Huma named for its successful and innovative approach to clinical trials in new UK government review

NEW YORK & LONDON, May 25 2023 Huma Therapeutics (“Huma”), a leading global digital health company, is named today as an exemplar of innovation in medical research in an independent review led by former Health Minister, Lord James O’Shaughnessy entitled Commercial clinical trials in the UK.

May 26, 2023
Announcement

Join us for our Ask the Expert session at MedTech Forum, Dublin on 31st May

Are you interested in the latest developments in digital health and their impact on the MedTech sector? Then mark your calendars for the Ask the Expert session at MedTech Forum in Dublin on 31 May.

May 26, 2023
Announcement

Welcome to next-generation digital-first care and research

Discover Huma's cutting-edge platform empowering clinicians with advanced digital capabilities to effectively diagnose, treat, and manage a wider patient population. Explore the reasons behind our breakthrough in delivering these enhanced capabilities.

May 24, 2023
Comment

Huma's innovative approach to tackling medication adherence

Medication non-adherence poses a significant problem that not only impacts the patient but also the healthcare system. Read this article and discover how Huma’s new medication module can help encourage medication adherence.

May 23, 2023
JOIN THE CONVERSATION

Discover our patents

Clinicians looking at a tablet.

Publications

User looking at a wrist watch.

Patents

Clinician speaking with a patient.

Articles

Learn more

Sign up to our newsletter

Huma is committed to respecting your privacy, we’ll always treat your personal details with the utmost care and will never sell them to other companies for marketing purposes. You can unsubscribe at any time. Review our Privacy Policy for further information.

Keep up to date on our current work and research with the latest marketing updates from Huma, including monthly news, events and communications on products and services.

One of our team members will be in touch with you shortly.
Oops! Something went wrong while submitting the form.
For all press enquiries, please contact: Karen Birmingham, Head of PR & Communications on karen.birmingham@huma.com

London

Millbank Tower
21-24 Millbank
London SW1P 4QP
UK

For all London enquiries

ldn@huma.com

New York

The Genome Center
101 6th Avenue
New York NY 10013
USA

For all New York
enquiries

nyc@huma.com

Shanghai

Room 123, 13th Floor
Shanghai Tower
No. 501 Yincheng Middle Road
China

For all China enquiries

shg@huma.com

Munich

(DACH-Region)
Huma Therapeutics GmbH
Raboisen 32
20095 Hamburg

For all enquiries

germany@huma.comaustria@huma.comswitzerland@huma.com